Novel SYNCO™
viable microbial product cattle
What is Novel SYNCO™?
Novel SYNCO™ is the combination of two revolutionary probiotic products from Novel Feed Technologies while lowering the cost to the end user. When other companies would clearly increase the price to increase their margins, we are passing along the savings created by combining the two products.
Novel SYNCO™ contains both Novel QUATTRO™ and Novel CBS™ and is the ultimate combination for pathogen inhibition and detoxification.
Why Novel QUATTRO™?
Novel QUATTRO™ is the first cattle specific four strain Bacillus based probiotic. Novel QUATTRO™ contains the proven foundation strains of B. subtilis and B. licheniformis. These two strains have been used in animal nutrition for over 30 years to control Clostridia, Salmonella, E. coli, and Listeria while producing digestive enzymes to enhance animal efficiency. The addition of B. coagulans and B. amyloliquefaciens are only found in Novel QUATTRO™. B. coagulans which is commonly used in human probiotics, was selected for its ability to produce lactic acid in the hind gut while B. amyloliquefaciens produces high quantities of beneficial enzymes. The result is a lethal combination.
As we say “Four Strains, Four Billion, for $0.04, That’s Novel QUATTRO™”
Why Novel CBS™?
Novel CBS™ is the live probiotic yeast Saccharomyces boulardii. Known for over 100 years, S. boulardii is the world’s #1 human probiotic today. The benefits are numerous, but its most unique benefit is that it is the only probiotic known to detoxify the toxins produced by Clostridia.
Why Feed Novel SYNCO™?
Novel SYNCO™ gives you the greatest possible pathogen protection.
Novel QUATTRO™ can kill and control many pathogens but like all warfare, some pathogens can slip through.
An illustration of Novel QUATTRO™ (Green Cells) excreting “bacteriocins” to kill pathogens such as Clostridia (Grey Cells).
Pathogens such as Clostridia (Grey Cells) excrete toxins that in turn cause animals to become sick.
Novel CBS™ (Tan Cells) of S. boulardii are proven to detoxify the toxins produced by Clostridia (Grey Cells).
This dual activity found ONLY in Novel SYNCO™ maximizes protection in the gut, eliminating the threat.
Novel QUATTRO™ = $0.040/h/d
Novel CBS™ = $0.048/h/d
OR
Novel SYNCO™ = $0.068/h/d
The choice is simple, “Choose Novel SYNCO!”